ReviewEuropean journal of clinical pharmacology2025

Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB).

Wenlu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.